drugset / Trial / NCT03792139
An Interaction Study of LY3200882 in Healthy Participants
NaSingle-groupOpen-labelBasic science
Summary
The main purpose of this study is to evaluate the effect of itraconazole on the amount of LY3200882 in the blood stream and how long the body takes to get rid of LY3200882. The safety and tolerability of LY3200882 when given with itraconazole will be evaluated. The study is expected to last up to 19 days from the first dose to follow-up (inclusive). Screening will occur up to 28 days prior to enrollment.
Timeline
- Start
- 2019-01-08
- Primary completion
- 2019-02-23
- Completion
- 2019-02-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Itraconazole | Small molecule | — | Oral |
| Subject | LY3200882 | Small molecule | — | Oral |
Indications
No indication recorded.